MedTrace Logo

Hypoparathyroidism Natural History Study

NCT05793853 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 106

Last updated 2025-12-16

No results posted yet for this study

Summary

This is a prospective three-year natural history study of adults with hypoparathyroidism. The goal is to monitor patients with hypoparathyroidism to define end-organ damage in the context of the disease.

The study objectives are to:

1. Build a prospective cohort of patients to study HPT-associated end-organ damage.
2. Determine end-organ physiologic consequences of HPT.
3. Elucidate determinants of HPT-associated end-organ damage.

Funding Source - FDA OOPD

Conditions

  • Hypoparathyroidism

Sponsors & Collaborators

Principal Investigators

  • Mishaela Rubin, MD · Columbia University

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-08-25
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05793853 on ClinicalTrials.gov